Boceprevir-based triple therapy for belgian liver transplant patients infected with hepatitis C virus: a preliminary experience.

MLA

Degre, Delphine, et al. “Boceprevir-Based Triple Therapy for Belgian Liver Transplant Patients Infected with Hepatitis C Virus: A Preliminary Experience.” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol. 19, no. 6, June 2013, pp. 669–70. EBSCOhost, https://doi.org/10.1002/lt.23645.

APA

Degre, D., Colle, I., Van Vlierberghe, H., & Moreno, C. (2013). Boceprevir-based triple therapy for belgian liver transplant patients infected with hepatitis C virus: a preliminary experience. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 19(6), 669–670. https://doi.org/10.1002/lt.23645

Chicago

Degre, Delphine, Isabelle Colle, Hans Van Vlierberghe, and Christophe Moreno. 2013. “Boceprevir-Based Triple Therapy for Belgian Liver Transplant Patients Infected with Hepatitis C Virus: A Preliminary Experience.” Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 19 (6): 669–70. doi:10.1002/lt.23645.